Older Men Are as Responsive as Young Men to the Anabolic Effects of Graded Doses of Testosterone on the Skeletal Muscle
The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
Abstract
Although testosterone levels and muscle mass decline with age, many older men have serum testosterone level in the normal range, leading to speculation about whether older men are less sensitive to testosterone. We determined the responsiveness of androgen-dependent outcomes to graded testosterone doses in older men and compared it to that in young men. The participants in this randomized, double-blind trial were 60 ambulatory, healthy, older men, 60-75 yr of age, who had normal serum testosterone levels. Their responses to graded doses of testosterone were compared with previous data in 61 men, 19-35 yr old. The participants received a long-acting GnRH agonist to suppress endogenous testosterone production and 25, 50, 125, 300, or 600 mg testosterone enanthate weekly for 20 wk. Fat-free mass, fat mass, muscle strength, sexual function, mood, visuospatial cognition, hormone levels, and safety measures were evaluated before, during, and after treatment. Of 60 older men who were randomized, 52 completed the study. After adjusting for testosterone dose, changes in serum total testosterone (change, -6.8, -1.9, +16.1, +49.5, and +101.9 nmol/liter at 25, 50, 125, 300, and 600 mg/wk, respectively) and hemoglobin (change, -3.6, +9.9, +20.9, +12.6, and +29.4 g/liter at 25, 50, 125, 300, and 600 mg/wk, respectively) levels were dose-related in older men and significantly greater in older men than young men (each P < 0.0001). The changes in FFM (-0.3, +1.7, +4.2, +5.6, and +7.3 kg, respectively, in five ascending dose groups) and muscle strength in older men were correlated with testosterone dose and concentrations and were not significantly different in young and older men. Changes in fat mass correlated inversely with testosterone dose (r = -0.54; P < 0.001) and were significantly different in young vs. older men (P < 0.0001); young men receiving 25- and 50-mg doses gained more fat mass than older men (P < 0.0001). Mood and visuospatial cognition did not change significantly in either group. Frequency of hematocrit greater than 54%, leg edema, and prostate events were numerically higher in older men than in young men. Older men are as responsive as young men to testosterone's anabolic effects; however, older men have lower testosterone clearance rates, higher increments in hemoglobin, and a higher frequency of adverse effects. Although substantial gains in muscle mass and strength can be realized in older men with supraphysiological testosterone doses, these high doses are associated with a high frequency of adverse effects. The best trade-off was achieved with a testosterone dose (125 mg) that was associated with high normal testosterone levels, low frequency of adverse events, and significant gains in fat-free mass and muscle strength.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are conflicting data on the effect of testosterone supplementation on muscle strength and function50,51,357,414.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [414]
In the citing paper
“Testosterone has a dose-dependent impact on fat-free mass in both the young and old, with higher levels associated with reduction in fat mass and increase in skeletal muscle mass and strength [43].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [43]
Citations
Cites
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
Self-citationAging of skeletal muscle: a 12-yr longitudinal study
Frontera, W. R., Hughes, V. A., Fielding, R. A., Fiatarone, M. A., Evans, W. J., & Roubenoff, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1321 · Cited by 1,443
GRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 7×
“The characteristics of young men have been described previously (29).”
BackgroundMethodResultInfluentialSelf-citationTestosterone Replacement in Older Hypogonadal Men: A 12-Month Randomized Controlled Trial
Sih, R. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.6.1661 · Cited by 922
Hughes, V. A., Frontera, W. R., Wood, M., Evans, W. J., Dallal, G. E., Roubenoff, R., & Singh, M. A. F. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.5.b209 · Cited by 921
Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women
Iannuzzi-Sucich, M., Prestwood, K. M., & Kenny, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.12.m772 · Cited by 890
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Cited by
Items 501–554 of 554
From prenatal life into senescence, testosterone is essential requirement for manhood.
Pradidarcheep, W., & Showpittapornchai, U. (2009) · PubMed · Cited by 1
Meikle, A. W. (2007) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70212-9
Montori, V. M., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., & Ronald, S. H. (2010)
13 Respiratoire revalidatie bij oudere patiënten met chronisch obstructief longlijden
Troosters, T., Gosselink, R., & Decramer, M. (2008) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-9490-6_13
Androgen Actions on Bone: Clinical Aspects
Goemaere, S., T'Sjoen, G. G., & Kaufman, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-459-9_17 · Cited by 1
Medically relevant variation in the human genome
Govindaraju, D. R., & Jorde, L. B. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0003
Iyer, R., & Handelsman, D. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_19 · Cited by 1
nasa (2018)
Testosterone therapy and physical function
Anawalt, B. D., & Page, S. T. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30202-x
Impact of Sarcopenia in Healthy Aging and Suggested Interventions
Erdoğan, T., Bahat, G., & Karan, M. A. (2018) · Springer eBooks · doi:10.1007/978-981-13-1699-9_20
Frailty and anabolic hormones in ageing men
O’Connell, M. D. L. (2011) · Research Explorer (The University of Manchester)
Burger, H. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718106470.793483637
Dhindsa, S. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch85
Wotring, V. E. (2012) · SpringerBriefs in space development · doi:10.1007/978-1-4614-3396-5_8
Hijazi, R. A., & Cunningham, G. R. (2006) · Elsevier eBooks · doi:10.1016/b978-012369391-4/50064-3
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000202323.44809.4f
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000224813.85060.ab
Harman, S. M. (2007) · Elsevier eBooks · doi:10.1016/b0-12-370870-2/00011-1
Meikle, A. W. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70635-7
Hypogonadism and Testosterone Therapy in Elderly Men
Yeap, B. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.66168-8
Doping Terhadap Kardiovaskular
Divisi Kardiologi Intervensi, R. J. D. S., Laksono, S., Hosea, G. T., & Fakultas Kedokteran Universitas Pelita Harapan, T. (2022) · Jurnal Porkes · doi:10.29408/porkes.v5i1.5407 · Cited by 1
(2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.002.0004
(2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.002.0003
(2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.002.0006
Utility and Limitations in Measuring Testosterone
Grossmann, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_4
Alikaei, Z., Azarbayjani, M. A., Atashak, S., Peeri, M., & Rahmati-Ahmadabad, S. (2023) · Thrita · doi:10.5812/thrita-139245
Hypogonadism and testosterone therapy in elderly men
Yeap, B. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00046-7
Nutzen und Grenzen bei der Messung von Testosteron
Grossmann, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_4
Missbrauch und Missbrauch von Testosteron
Iyer, R., & Handelsman, D. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_23
Sportif Performans Açısından İzokinetik Kuvvet Değerlendirme ve Yorumlama
Yılmaz, H. H., & Daşkesen, S. S. (2024) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub640.c2774
Spor Mimarisi ve Dijital Teknolojilerin Kesişimi
Dertli, M. E., & Dertli, Ş. (2024) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub640.c2775
Er, F. (2024) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub640.c2770
Video Analiz Yönteminin Performans ve Teknik Gelişimine Katkısı (Alp Disiplini Örneği)
Aktaş, B. S. (2024) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub640.c2793
Sarcopenia and Osteoporosis: Two Sides of the Same Coin
Anil, A., Agrawal, S., Panthackel, M., & Dave, B. R. (2025) · Indian Spine Journal · doi:10.4103/isj.isj_91_24
Testosterone Therapy in Men with Functional Hypogonadism
Mauvais‐Jarvis, F. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_15
Kolliari-Turner, A., Lima, G. H. O., Wang, G., Malinsky, F. R., Karanikolou, A., Eichhorn, G., Tanisawa, K., Betancurt, J. A. O., Hamilton, B., Kumi, P. Y. O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586666
Kolliari-Turner, A., Lima, G. H. O., Wang, G., Malinsky, F. R., Karanikolou, A., Eichhorn, G., Tanisawa, K., Betancurt, J. A. O., Hamilton, B., Kumi, P. Y. O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586669
Kolliari-Turner, A., Lima, G. H. O., Wang, G., Malinsky, F. R., Karanikolou, A., Eichhorn, G., Tanisawa, K., Betancurt, J. A. O., Hamilton, B., Kumi, P. Y. O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586654
Kolliari-Turner, A., Lima, G. H. O., Wang, G., Malinsky, F. R., Karanikolou, A., Eichhorn, G., Tanisawa, K., Betancurt, J. A. O., Hamilton, B., Kumi, P. Y. O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586663
Kolliari-Turner, A., Lima, G. H. O., Wang, G., Malinsky, F. R., Karanikolou, A., Eichhorn, G., Tanisawa, K., Betancurt, J. A. O., Hamilton, B., Kumi, P. Y. O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586660
Kolliari-Turner, A., Lima, G. H. O., Wang, G., Malinsky, F. R., Karanikolou, A., Eichhorn, G., Tanisawa, K., Betancurt, J. A. O., Hamilton, B., Kumi, P. Y. O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586657
Kolliari-Turner, A., Lima, G. H. O., Wang, G., Malinsky, F. R., Karanikolou, A., Eichhorn, G., Tanisawa, K., Betancurt, J. A. O., Hamilton, B., Kumi, P. Y. O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586651
Preventing Atherosclerotic Cardiovascular Disease in Young Male Androgen Abusers
Bond, P., Smit, D. L., Verdegaal, T. J., & de Ronde, W. (2026) · Clinical Cardiology · doi:10.1002/clc.70257
“C levels are generally unaffected by injectable androgens such as testosterone enanthate (up to 600 mg weekly) and nandrolone decanoate (up to 200 mg weekly) [13, 28, 29, 31–33, 35, 36], although this may also be an artifact of the androgen dosages used that may not represent real‐world usage.”
Testostérone plasmatique et risque cardiovasculaire chez les hommes après 65 ans
Soisson, V. (2013) · theses.fr (ABES) · doi:10.70675/a221c7c6zbab2z45a7zbccfz9a65a34e7613
Mahamadou, A. N. L. (2018) · theses.fr (ABES) · doi:10.70675/e3a8c8b3z1d51z4ae0z8830z7b911248b588
“En effet, la testostérone pourrait favoriser la rétention hydro-sodée chez les hommes au cours du vieillissement et ce mécanisme pourrait contribuer au développement d’une hypertension artérielle et d’une insuffisance cardiaque [161].”
Genome-wide analyses of signaling pathways controlled by steroid receptors
Rerra, A. (2019) · theses.fr (ABES) · doi:10.70675/d10332bfzd22cz480cz8f5czc0114d6c93c5
Trans-Inclusion in Sports: History, Scientific Evidence and Future Directions
Krishna, A. M., Bauer, C., Way, K. L., Jones, B., Cheung, A. S., & Lamon, S. (2026) · International Journal of Sports Medicine · doi:10.1055/a-2893-8339
Câmara, L. C., & Ferreira, M. H. L. (2026) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v7i8.8670
BindingDB (2013) · UC San Diego · doi:10.7270/q2xw4kxm
Metadata
- Authors
- Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Mac, R. P., Lee, M., Yarasheski, K. E., Sinha-Hikim, I., Dzekov, C., Dzekov, J., Magliano, L., & Storer, T. W.
- Affiliations
- University of California, Los Angeles (US)
- Charles R. Drew University of Medicine and Science (US)
- Washington University in St. Louis (US)
- El Camino College (US)
- Corresponding author
- Bhasin, Shalender
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-02
- Volume
- 90
- Issue
- 2
- Pages
- 678-688
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2133467178
- Cited by
- 544
- References
- 73
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 23 · 2023: 16 · 2022: 30 · 2021: 13 · 2020: 19 · 2019: 17 · 2018: 30 · 2017: 28 · 2016: 17 · 2015: 19 · 2014: 22 · 2013: 29 · 2012: 22
- FWCI
- 28.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p41rr000954-34, 5u01dk054047-06)
- National Institute on Aging (1R01 AG-14369-01, R01AG014369)
- National Institute of General Medical Sciences (GM-00425)
- National Institute of Diabetes and Digestive and Kidney Diseases (1R01 DK 59627-01, U01-DK-54047, R01DK049296, 2R01DK49296-02A, R01DK059627)
- National Center for Research Resources (G12 RR 03026, P41-RR000954, P20RR11145, 5P41-RR-000954, G12RR003026, P20RR011145)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD041748, R01HD043348)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- older men, androgen response, skeletal muscle, fat-free mass, fat mass, muscle strength, sexual function, mood, visuospatial cognition, GnRH agonist, testosterone replacement therapy, aging, hemoglobin response, adverse effects, treatment discontinuation
- MeSH terms
- Adult, Age Factors, Aged, Aging, Energy Intake, Exercise Test, Humans, Luteinizing Hormone, Male, Middle Aged, Sexual Behavior, Sex Hormone-Binding Globulin, Testosterone, Leuprolide, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.